299,324 Shares in Amrize Ltd $AMRZ Purchased by Marshall Wace LLP

Marshall Wace LLP purchased a new stake in shares of Amrize Ltd (NYSE:AMRZFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 299,324 shares of the company’s stock, valued at approximately $14,873,000.

Several other large investors have also recently added to or reduced their stakes in AMRZ. Vanguard Group Inc. acquired a new stake in shares of Amrize during the 2nd quarter worth approximately $1,065,029,000. Norges Bank acquired a new position in shares of Amrize in the second quarter valued at $670,915,000. Dodge & Cox bought a new position in Amrize in the second quarter worth $622,085,000. JPMorgan Chase & Co. bought a new position in Amrize in the second quarter worth $220,404,000. Finally, Legal & General Group Plc acquired a new stake in Amrize during the second quarter worth $161,761,000.

Insider Activity

In other Amrize news, CEO Jan Philipp Jenisch bought 55,000 shares of Amrize stock in a transaction dated Thursday, October 30th. The shares were acquired at an average cost of $52.64 per share, with a total value of $2,895,200.00. Following the acquisition, the chief executive officer directly owned 1,505,000 shares of the company’s stock, valued at $79,223,200. The trade was a 3.79% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CTO Roald Brouwer purchased 4,000 shares of the firm’s stock in a transaction that occurred on Friday, October 31st. The shares were acquired at an average price of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the transaction, the chief technology officer owned 9,000 shares in the company, valued at $465,930. The trade was a 80.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have purchased 65,000 shares of company stock worth $3,399,720.

Analyst Upgrades and Downgrades

AMRZ has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Amrize to a “hold” rating in a research note on Saturday, October 25th. Oppenheimer assumed coverage on shares of Amrize in a research note on Tuesday, September 9th. They issued an “outperform” rating and a $62.00 target price on the stock. Citigroup increased their price target on shares of Amrize from $60.00 to $63.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Stephens started coverage on shares of Amrize in a research note on Friday, November 14th. They set an “overweight” rating and a $60.00 price target for the company. Finally, UBS Group lifted their price objective on Amrize from $52.00 to $53.00 and gave the company a “neutral” rating in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $59.00.

View Our Latest Analysis on AMRZ

Amrize Stock Performance

AMRZ opened at $53.49 on Wednesday. The stock has a 50-day moving average price of $49.74. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $56.29. The company has a market cap of $29.59 billion and a price-to-earnings ratio of 29.07.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.03). The company had revenue of $3.68 billion for the quarter, compared to analysts’ expectations of $3.49 billion. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year.

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.